Abstract
Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) leads to rapidly progressive dementia and is caused by mutations in the gene CSF1R. Neurodegeneration is driven by dysfunction of microglia, the predominant cell type expressing CSF1R in the brain. We assessed chitotriosidase, an enzyme secreted by microglia, in serum and cerebrospinal fluid of patients with ALSP. Chitotriosidase activity was highly increased in cerebrospinal fluid of patients and correlated inversely with disease duration. Of interest, presymptomatic CSF1R mutation carriers did not show elevated chitotriosidase levels. This makes chitotriosidase a promising new biomarker of disease activity for this rare disease.
Cite
CITATION STYLE
Hayer, S. N., Santhanakumaran, V., Böhringer, J., & Schöls, L. (2022). Chitotriosidase is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Annals of Clinical and Translational Neurology, 9(11), 1807–1812. https://doi.org/10.1002/acn3.51656
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.